Professor joins pSiMedica

pSivida’s UK subsidiary pSiMedica has added to its team, appointing Texan professor Jeffrey Coffer as a collaborator. Professor Coffer’s professional background includes research into semiconductor nanocrystal synthesis, properties and characterization, with particular reference to porous silicon. pSivida, a local listed nanotechnology company, is developing porous silicon medical applications in drug delivery and orthopaedics for its trademarked product BioSilicon.

Professor Coffer has focused his most recent research in BioSilicon™ in the fields of orthopaedics and tissue engineering, as well as researching silicon nanowires and rare earth incorporation into porous silicon for optoelectrical and biomedical applications.

Add your comment

BNIQ sponsored byECU School of Business and Law


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
49 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer